Ashler et Manson (XPAR:MLAEM) Total Liabilities: €0.43 Mil (As of Dec. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAR:MLAEM Ashler et Manson SA XPAR:MLAEM
80 GF Score
Price €3.04
GF Value €2.62
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is Ashler et Manson Total Liabilities?

Ashler et Manson XPAR:MLAEM 80 Total Liabilities is €0.43 Mil as of Dec. 2024. GuruFocus rates XPAR:MLAEM with a GF Score™ of 80/100 and a GF Value™ of €2.62 (Modestly Overvalued). The stock has 2 warning signs investors should review.

Ashler et Manson's Total Liabilities for the quarter that ended in Dec. 2024 was €0.43 Mil.

Ashler et Manson's quarterly Total Liabilities declined from Dec. 2022 (€1.85 Mil) to Dec. 2023 (€0.77 Mil) and declined from Dec. 2023 (€0.77 Mil) to Dec. 2024 (€0.43 Mil).

Ashler et Manson's annual Total Liabilities declined from Dec. 2022 (€1.85 Mil) to Dec. 2023 (€0.77 Mil) and declined from Dec. 2023 (€0.77 Mil) to Dec. 2024 (€0.43 Mil).


Ashler et Manson Total Liabilities Historical Data

* Premium members only.

The historical data trend for Ashler et Manson's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ashler et Manson Total Liabilities Chart

Ashler et Manson Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.51 1.62 1.85 0.77 0.43

Ashler et Manson Semi-Annual Data
Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.51 1.62 1.85 0.77 0.43
XPAR:MLAEM
80GF Score
Ashler et Manson SA XPAR:MLAEM
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ashler et Manson Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Ashler et Manson's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities=Total Assets (A: Dec. 2024 )-Total Equity (A: Dec. 2024 )
=1.803-1.374
=0.43

Ashler et Manson's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities=Total Assets (Q: Dec. 2024 )-Total Equity (Q: Dec. 2024 )
=1.803-1.374
=0.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of €0.43 Mil mean?
Ashler et Manson (XPAR:MLAEM) has a Total Liabilities of €0.43 Mil as of Dec. 2024. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Ashler et Manson and its competitors.
Is Ashler et Manson's Total Liabilities too high?
Ashler et Manson's current Total Liabilities is €0.43 Mil. Overall, Ashler et Manson has a GF Score™ of 80/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ashler et Manson's Total Liabilities compare to MRSH and AON?
Ashler et Manson's Total Liabilities of €0.43 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for an Insurance company?
A good Total Liabilities depends on the Insurance industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Ashler et Manson and its competitors. Ashler et Manson's current Total Liabilities is €0.43 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ashler et Manson stock overvalued right now?
Based on GuruFocus' analysis, Ashler et Manson (XPAR:MLAEM) is currently considered Modestly Overvalued. The stock's GF Value™ is €2.62, compared to a current price of €3.04 — trading 16% above its estimated fair value. The current Total Liabilities is €0.43 Mil. Ashler et Manson's overall GF Score™ is 80/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Ashler et Manson (XPAR:MLAEM), the current Total Liabilities is €0.43 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ashler et Manson (XPAR:MLAEM) Overvalued in 2026?

Based on GuruFocus' analysis, Ashler et Manson stock appears to be overvalued. The current stock price of €3.04 is trading 16% above its estimated GF Value™ of €2.62. GuruFocus considers Ashler et Manson to be Modestly Overvalued.

Key valuation signals for XPAR:MLAEM:

  • Total Liabilities: €0.43 Mil
  • GF Value™: €2.62 vs. price of €3.04 (16% above fair value)
  • GF Score™: 80/100 with 2 warning signs

No single metric tells the full story. See the XPAR:MLAEM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ashler et Manson Business Description

Address 2 Allees d'Orleans, Bordeaux, FRA, 33000
Ashler et Manson SA is a France-based brokerage group in real estate credit and loan insurance sector.
80GF Score

Get the complete analysis for XPAR:MLAEM

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.04
Price
€2.62
GF Value